Print Page | Contact Us
Share |

Nonalcoholic Fatty Liver Disease
"The Tsunami in the Waiting Room" 

Presented by Lyn Patrick, ND

 

In early 2016 the mass media finally started talking about NASH (nonalcoholic steatohepatitis). “According to liver experts, NASH is a silent public health time bomb that may soon overload our health care system with hospital admissions. By 2020, it is expected to eclipse hepatitis C as the leading reason for liver transplants.”


“NASH IS THE 21ST CENTURY’S LOOMING PUBLIC HEALTH THREAT“ was the headline in Newsweek’s January 30th edition and featured a story of an overweight 52 year-old retired special ed teacher who was diagnosed with cirrhosis. Her only symptom was fatigue and she had no history of drug or alcohol abuse or viral hepatitis.

 

When I was working with a team of hepatologists ten years ago designing a clinical trial for hepatitis C that included using Chinese herbs, we were warned about an epidemic of NASH (especially in hepatitis C patients) and it’s capacity to bankrupt the healthcare system. Well, fast forward 10 years later and it’s now estimated to affect 30% of the adult

"I encourage you all to gain access to this information and become experts in the assessment, diagnosis and treatment of NAFLD/NASH."


population in the U.S. and 10% of children. The majority of those with fatty liver disease are undiagnosed and a significant percentage of them will progress to NASH where they face a risk of cirrhosis and hepatocellular carcinoma. How did we get here? How do we get out?

 

After lecturing about this topic for the past 10 years and treating a significant number of hepatitis C positive and negative patients who are battling fatty liver and NASH, I’ve put together a series of webinars on both basic hepatology and the etiology of nonalcoholic fatty liver and it’s relationship to insulin resistance, obesity, toxicant exposure, and type 2 diabetes. The solutions? Dietary guidance, weight loss via increasing insulin sensitivity, exercise, botanical medicine, nutritional supplementation and careful management. Some of the content has been “borrowed” from our Hepatitis C Training Course and applies just as well to those without hepatitis C as it does to our hepatitis C positive patients.

 

Pricing:

Package Pricing

 

$175

 

6 individual recordings

11 CE hours at less than $16 a CE hour!! 

  

  

PURCHASE RECORDING

PACKAGE

  

Individual recording pricing listed below

Purchase Includes:  

 

  • Unlimited access to recording(s)
  • No view limits 
  • No cap on handout and resources downloads
  • Recording(s) archived to your PME profile for viewing on your schedule
  • Approved for CE by the Oregon Board of Naturopathic Medicine and California Acupuncture Board




 

Preview Recordings

Click on "View More" for specific learning objectives or to purchase individual recordings

 Hep 101: How the Liver Really Works in Health & Disease

2.00 CE  // $36

View More

Hep 103: Labs, Imaging, & Biopsy

1.50 CE // $27

View More

Cirrhosis, Fibrosis, Hepatic Encephalopathy

1.75 CE // $31.50

View More


 

 

   

Introduction to Nonalcoholic
Fatty Liver Disease:  
Epidemiology, Assessment, and Treatment

2.25 CE // $40.50

View More

Fibrosis to Cirrhosis:
How to Diagnose and Treat Liver Progression and Damage in Hep C

1.75 CE // $31.50

View More

Drug/Herb Interactions: More About Herbs, Nutrients, and Medications

1.75 CE // $31.50

View More


 

"NAFLD is recognized today as the most common liver disease in the Western population, with estimated prevalence rates of 20-46%."

     

 

Aliment Pharmacol Ther 2011;34: 274-285

"Among persons who were obese, the prevalence of steatosis increased from 23% in the 1980's to 49% in the 1990's and to 60% in the last decade. 

 

 Even in non-obese patients, the prevalence of steatosis increased from 12% (1980's) to 27% (1990's) to 36% (2012)."  


Digestive Disease Week 2012; May 19-22, 2012;

San Diego, CA. Abstract 1054


Lyn Patrick, ND

Lyn Patrick, ND graduated from Bastyr University in 1984 and has been in private practice for 27 years. She has been a faculty member of the American College for Advancement in Medicine (www.acam.org) continuing medical education conferences, lecturing in the area of metal toxicology and environmental medicine and has served on the Board of Directors at ACAM. She has lectured for the Institute of Functional Medicine and many physician membership organizations nationally and internationally on the subject of environmental medicine.

Dr. Patrick is a published author of numerous articles in peer-reviewed medical journals and has been a longtime Contributing Editor for Alternative Medicine Review, a Medline-indexed journal of complementary/alternative medical research (www.altmedrev.com).  

 

 

NAFLD Mentorship Interest List

Are your interested in receiving guidance on NAFLD? PME is considering offering a mentorship program for physicians and healthcare professionals who have at-risk patients or patients diagnosed with NAFLD. Join the interest list to receive updates on this future program.